Brief: Heartbeam Issues Shareholder Letter And Provides Corporate Update
29/12/2022 13:46
Dec 29 (Reuters) - Heartbeam Inc BEAT.O :
* HEARTBEAM ISSUES SHAREHOLDER LETTER AND PROVIDES CORPORATE
UPDATE
* HEARTBEAM INC - EXPECT HEARTBEAM AIMI SYSTEM FOR USE IN
ACUTE
CARE SETTINGS TO RECEIVE REGULATORY APPROVAL IN NEAR FUTURE
* HEARTBEAM INC - ARE IN DISCUSSIONS WITH FDA AND PLAN TO
MEET
WITH THEM SOON AND EXPECT HEARTBEAM AIMI TO BE CLEARED IN Q1
2023 TIME FRAME
* HEARTBEAM INC - ANTICIPATE HEARTBEAM AIMIGO VERSION 2
DEVICE
WITH SYNTHESIZED 12L CAPABILITY TO BE READY FOR FDA SUBMISSION
AT END OF Q2 2023
Source text for Eikon: ID:nBwbb9QCVa
Further company coverage: BEAT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Heartbeam
See all newsBrief: Heartbeam Announces Strategic Shift To Accelerate Global Adoption Of Its Ambulatory ECG Signal Platform And Leadership Transition
Brief: Heartbeam Reports First Quarter 2026 Results
HeartBeam Q1 net loss narrows as commercialization advances
Brief: Heartbeam Initiates Pilot Study Of First On-Demand 12-Lead ECG Patch To Detect Ischemia Outside The Clinic
Brief: Heartbeam Expands Commercial Presence Across Four Key U.S. Markets With Addition Of Premier Concierge Practice